From: Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study
Cytology result
No previous radiotherapy
Previous radiotherapy
PR
95% CI (PR)
N (%)
ASCUS + ASCH + AGC
41 (32.5)
10 (50.0)
1.54
0.93 – 2.55
LSIL
20 (15.9)
2 (10.0)
0.63
0.16 – 2.49
HSIL or worse
65 (51.6)
8 (40.0)
0.78
0.44 – 1.36